PetMed Express Files 8-K: Board & Compensation Updates

Ticker: PETS · Form: 8-K · Filed: 2024-04-29T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, executive-compensation, filing-update

Related Tickers: PETS

TL;DR

PETS filed an 8-K on 4/29 for board changes and comp. Nothing major yet.

AI Summary

PetMed Express, Inc. filed an 8-K on April 29, 2024, reporting changes in its board of directors and executive compensation arrangements. The filing also includes financial statements and exhibits, indicating ongoing corporate governance and financial disclosures.

Why It Matters

This filing signals potential shifts in the company's leadership and incentive structures, which could impact strategic direction and investor confidence.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not contain information about significant financial distress or operational failures.

Key Players & Entities

FAQ

What specific changes were made to the board of directors?

The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" as an item of disclosure, but the specific names and details of these changes are not provided in the provided text.

What are the details of the compensatory arrangements for certain officers?

The filing lists "Compensatory Arrangements of Certain Officers" as an item, but the specific details of these arrangements are not included in the provided text.

What is the purpose of filing financial statements and exhibits?

The filing includes "Financial Statements and Exhibits" as an item, which is standard for an 8-K to provide supporting documentation for the reported events or to update financial information.

When was PetMed Express, Inc. incorporated?

PetMed Express, Inc. was incorporated in Florida, as indicated by the filing.

What is the company's fiscal year end?

The company's fiscal year ends on March 31st, as stated in the filing.

From the Filing

0001040130-24-000022.txt : 20240429 0001040130-24-000022.hdr.sgml : 20240429 20240429081745 ACCESSION NUMBER: 0001040130-24-000022 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240429 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240429 DATE AS OF CHANGE: 20240429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28827 FILM NUMBER: 24886707 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20240429.htm 8-K pets-20240429 0001040130 FALSE 0001040130 2024-04-29 2024-04-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  April 29, 2024 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Transition and Separation Agreement with Mathew Hulett On April 29, 2024, PetMed Express, Inc. (the “Company”) and Mathew Hulett entered into a Transition and Separation Agreement pursuant to which Mr. Hulett resigned as President and Chief Executive Officer, and also as a director, of the Company effective April 29, 2024 (the “Separation Agreement”). Under the terms of the Separation Agreement, Mr. Hulett will remain employed by the Company through May 10, 2024 to assist the Company in transition matters, and the Company will pay Mr

View on Read The Filing